Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Amgen Inc (AMGN)

Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 148,224,736
  • Shares Outstanding, K 537,533
  • Annual Sales, $ 28,190 M
  • Annual Income, $ 6,717 M
  • EBIT $ 6,218 M
  • EBITDA $ 10,289 M
  • 60-Month Beta 0.55
  • Price/Sales 5.29
  • Price/Cash Flow 10.53
  • Price/Book 19.83

Options Overview Details

View History
  • Implied Volatility 24.26% ( +0.17%)
  • Historical Volatility 32.32%
  • IV Percentile 59%
  • IV Rank 16.26%
  • IV High 55.92% on 11/20/24
  • IV Low 18.11% on 05/21/24
  • Put/Call Vol Ratio 0.14
  • Today's Volume 15,533
  • Volume Avg (30-Day) 25,160
  • Put/Call OI Ratio 0.83
  • Today's Open Interest 224,678
  • Open Int (30-Day) 214,877

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 29 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 4.97
  • Number of Estimates 12
  • High Estimate 5.27
  • Low Estimate 4.71
  • Prior Year 4.71
  • Growth Rate Est. (year over year) +5.52%

Price Performance

See More
Period Period Low Period High Performance
1-Month
257.80 +6.74%
on 11/26/24
321.22 -14.34%
on 11/12/24
-46.64 (-14.49%)
since 11/11/24
3-Month
257.80 +6.74%
on 11/26/24
339.17 -18.87%
on 09/23/24
-54.81 (-16.61%)
since 09/11/24
52-Week
257.80 +6.74%
on 11/26/24
346.85 -20.67%
on 07/25/24
+3.03 (+1.11%)
since 12/11/23

Most Recent Stories

More News
2 No-Brainer Dividend Stocks With Yields Over 3% to Buy in 2025 and Hold for a Decade or Longer

Whether you're looking for a way to beat the benchmark S&P 500 index or you just want a steady flow of passive income, dividend-paying stocks are a great way to achieve your investment goals.

KO : 62.64 (-0.43%)
AZN : 67.35 (+0.25%)
AMGN : 275.68 (-0.03%)
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?

Looking for reliable income in the stock market? You might want to consider the top Dogs of the Dow in December. Here's what you need to know about this trio of blue-chip stocks.

SHW : 372.56 (+0.26%)
VZ : 42.00 (-0.71%)
CVX : 156.69 (-0.20%)
INTC : 20.15 (-0.05%)
WBA : 9.77 (-6.24%)
$DOWI : 44,260.23 (+0.03%)
AMGN : 275.68 (-0.03%)
DIA : 443.32 (-0.08%)
MarketBeat Week in Review – 12/2 - 12/6

Equities continued their post-election rally after Friday’s solid November jobs report and all signs point to the rally in stocks extending into 2025

NFLX : 937.47 (+2.64%)
NVDA : 139.87 (+3.55%)
TSLA : 419.10 (+4.52%)
ULTA : 431.72 (+4.81%)
LYFT : 15.49 (-4.32%)
LLY : 796.84 (-0.34%)
RIVN : 13.71 (-2.49%)
RKLB : 23.63 (+3.41%)
UBER : 61.85 (-4.79%)
AMGN : 275.68 (-0.03%)
TSM : 194.67 (+1.42%)
CRM : 357.09 (+2.37%)
Amgen Stock Falls on Weight Loss Drug Data: Overreaction or Fair?

Results for Amgen's weight loss drug Maritide were highly anticipated, but fell short. However, MariTide could still turn the tables in future studies.

NVO : 111.60 (+2.21%)
LLY : 796.84 (-0.34%)
AMGN : 275.68 (-0.03%)
Is Regeneron Pharmaceuticals Stock Underperforming the Nasdaq?

Despite Regeneron Pharmaceuticals’ significant underperformance relative to Nasdaq recently, Wall Street analysts remain strongly optimistic about the stock’s prospects.

$NASX : 20,043.10 (+1.81%)
REGN : 780.40 (+0.24%)
AMGN : 275.68 (-0.03%)
Is Amgen Still a Top Dividend Stock?

The relationship between interest rates and dividend stocks tends to follow a predictable pattern. When the Federal Reserve signals a shift toward monetary easing, investors often rotate toward stable,...

AMGN : 275.68 (-0.03%)
This Healthcare Stock Is a Favorite of Billionaires. But Is It a Buy?

Unsurprisingly, these stock pickers are capitalizing on an opportunity that's only recently become addressable.

NVO : 111.60 (+2.21%)
MRK : 99.97 (-1.02%)
LLY : 796.84 (-0.34%)
AMGN : 275.68 (-0.03%)
PFE : 25.29 (-1.10%)
UNH : 538.40 (-4.74%)
Gilead Sciences Stock: Is GILD Outperforming the Healthcare Sector?

Gilead Sciences has recently demonstrated strong performance, outperforming the broader healthcare sector, and analysts maintain a cautiously optimistic outlook on its future.

XLV : 142.53 (-1.09%)
GILD : 92.37 (+0.03%)
AMGN : 275.68 (-0.03%)
Top Stock Reports for Amgen, Eaton & Enzo Biochem

Wednesday, December 4, 2024The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Amgen Inc....

SONY : 22.18 (+1.88%)
META : 631.12 (+1.91%)
MO : 55.05 (-0.79%)
GD : 264.86 (-2.06%)
AMGN : 275.68 (-0.03%)
ETN : 363.71 (+1.46%)
Is Amgen Stock Underperforming the Dow?

Despite pharma giant Amgen trailing behind the Dow index over the past three months, analysts remain cautiously bullish about the stock's growth potential.

$DOWI : 44,260.23 (+0.03%)
GILD : 92.37 (+0.03%)
AMGN : 275.68 (-0.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two...

See More

Key Turning Points

3rd Resistance Point 283.85
2nd Resistance Point 280.88
1st Resistance Point 278.31
Last Price 275.68
1st Support Level 272.77
2nd Support Level 269.80
3rd Support Level 267.23

See More

52-Week High 346.85
Fibonacci 61.8% 312.83
Fibonacci 50% 302.33
Fibonacci 38.2% 291.82
Last Price 275.68
52-Week Low 257.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar